Home > Blog

Blog | Veristat, The Science-First CRO

Gain the latest insights and trends in clinical trials, patient recruitment, data analysis, adaptive design, regulatory submissions and approvals.

Sign Up Today

Strategic Consulting

2 min read

Cross-Functional Collaboration: A Cornerstone of Successful Clinical Development

Complex therapeutic development requires deep integration across clinical, regulatory, statistical, and operational functions. Whether optimizing dose, navigating regulatory pathways, or accelerating timelines, early and sustained collaboration is...

READ MORE

3 min read

Project Optimus Explained: Why the FDA is Shifting Away from Maximum Tolerated Dose in Oncology

Historically, oncology drug development followed a straightforward principle: identify the highest dose patients could tolerate without unacceptable side effects, then use that dose in subsequent trials and clinical practice. This maximum tolerated dose...

READ MORE

2 min read

Staying Ahead of Regulatory Change: CMC Strategies for Cell and Gene Therapy Development

The regulatory landscape for cell and gene therapies (CGTs) is shifting fast. From increased scrutiny on Chemistry, Manufacturing, and Controls (CMC) to operational challenges at the U.S. Food and Drug Administration (FDA), sponsors must be prepared to...

READ MORE

3 min read

Top 3 Tips for Choosing the Right Oncology CRO

The decision to partner with a Clinical Research Organization (CRO) is never taken lightly—especially in oncology. With high complexity, accelerated timelines, and evolving regulatory expectations, the stakes in oncology drug development are uniquely...

READ MORE

3 min read

Bayesian Study Designs in Early-Phase Oncology Trials

The development of innovative oncology therapies has evolved dramatically, moving beyond traditional chemotherapies to include immunotherapies, targeted agents, radiotherapies, and cell and gene therapies. As these new modalities emerge, the limitations...

READ MORE

1 min read

Achieve Regulatory Excellence and Accelerate Your Clinical Trials with Veristat

Learn how Veristat’s multidisciplinary team helped sponsors navigate the complexities of global regulatory submissions, achieving early and successful outcomes.

READ MORE

4 min read

Webinar Q&A: How to Advance New Cancer Therapies in Alignment with FDA Project FrontRunner

In partnership with Clinical Leader, Veristat consulting, regulatory, and clinical experts gave a live webinar outlining how to better advance new cancer therapies in alignment with FDA’s Project FrontRunner. The webinar covered the following:

  • What is...
READ MORE

1 min read

Harness the FDA's Project FrontRunner to Advance Your New Oncology Therapies

Are you interested in learning about the latest FDA initiative to accelerate the development of new cancer treatments? Veristat's informative webinar "Advancing Development of New Oncology Therapies, aligning with FDA's Project FrontRunner" is an...

READ MORE

1 min read

How Veristat Helped a Global Pharma Company Navigate Complex Medical Writing Challenges

Learn how Veristat's expert medical writing team supported a global specialty pharmaceutical company with 130+ projects for rare disease treatments. Our longstanding thirteen-year relationship, built on trust and quality, continues to thrive as we help...

READ MORE

2 min read

Navigating the IND Submission Labyrinth: A Veristat Success Story

At Veristat, we pride ourselves on transforming challenges into triumphs, particularly in the complex pharmaceutical and biotech development world. Our recent collaboration with a small-sized biotech company targeting cancers of the reproductive system...

READ MORE